Andreas Probst, Alanna Ebigbo, Stefan Eser, Carola Fleischmann, Tina Schaller, Bruno Märkl, Stefan Schiele, Bernd Geissler, Gernot Müller, Helmut Messmann
Clin Endosc 2023;56(1):55-64. Published online January 13, 2023
Background /Aims: Endoscopic submucosal dissection (ESD) has been established as a treatment modality for superficial esophageal squamous cell carcinoma (ESCC). Long-term follow-up data are lacking in Western countries. The aim of this study was to analyze long-term survival in a Western center.
Methods Patients undergoing ESD for ESCC were included. The analysis was performed retrospectively using a prospectively collected database.
Results R0 resection rate was 96.7% (59/61 lesions in 58 patients). Twenty-seven patients (46.6%) fulfilled the curative resection criteria (M1/M2) (group A), 11 patients (19.0%) had M3 lesions without lymphovascular invasion (LVI) (group B), and 20 patients (34.5%) had lesions with submucosal invasion or LVI (group C). Additional treatment was recommended after non-curative resection. It was not performed in 20/31 patients (64.5%), mainly because of comorbidities (75%). Twenty-nine out of 58 (50.0%) patients died during a mean follow-up of 3.7 years. Death was related to ESCC in 17.2% (5/29) of patients. The disease-specific survival rate after curative resection was 100%. Overall survival rates after 5 years were 61.5%, 63.6% and 28.1% for groups A, B, and C, respectively. The overall survival was significantly worse after non-curative resection (p=0.038).
Conclusions Non-curative resection is frequent after ESD for ESCC in Western patients. The long-term prognosis is limited and mainly determined by comorbidity. Early diagnosis and pre-interventional assessments need to be improved.
Citations
Citations to this article as recorded by
Endoscopic submucosal dissection in early esophageal neoplasia: Celebrating efficacy, confronting heterogeneity, and refining surveillance for high-risk patients Shi-Qiong Zhou, Qing-Hua Ke World Journal of Clinical Oncology.2026;[Epub] CrossRef
Outcomes of endoscopic submucosal dissection for superficial esophageal squamous neoplasms: a multicenter North American experience Rishi Subrahmanyan, Hiroyuki Aihara, Anand Kumar, Alexander Schlachterman, Shai Friedland, Joo Ha Hwang, Mohamed Othman, Salmaan Jawaid, Lorenzo Ferri, Christopher Teshima, Jeffrey Mosko, Robert Bechara, Jason Samarasena, Dennis Yang, Michael Ujiki, Yutak Gastrointestinal Endoscopy.2025;[Epub] CrossRef
Endoscopic resection of early esophageal neoplasia in patients with esophageal varices: a systematic review Charlotte N. Frederiks, Laura S. Boer, Bas Gloudemans, Lorenza Alvarez Herrero, Jacques J.G.H.M. Bergman, Roos E. Pouw, Bas L.A.M. Weusten Endoscopy.2025; 57(07): 769. CrossRef
Non-Curative Endoscopic Submucosal Dissection: Current Concepts, Pitfalls and Future Perspectives João Santos-Antunes Journal of Clinical Medicine.2025; 14(7): 2488. CrossRef
Feasibility and predictors of same-day discharge following endoscopic submucosal dissection for early esophageal cancer Yu-ping Yuan, Chi-chao Wang, Yuan-liang Zheng BMC Gastroenterology.2025;[Epub] CrossRef
Navigating the Treatment Landscape for Widespread Superficial Esophageal Squamous Cell Neoplasia Moon Won Lee, Gwang Ha Kim Gut and Liver.2025; 19(3): 305. CrossRef
Endoscopic submucosal dissection in the West: tips and tricks for successful resection Roberta Maselli Gastrointestinal Endoscopy.2025; 102(4): 488. CrossRef
Endoscopic submucosal dissection for early gastrointestinal malignancies: Current state and future perspectives Sandip Pal, Gourab Bhaduri World Journal of Gastrointestinal Endoscopy.2025;[Epub] CrossRef
Endoscopic submucosal dissection for early esophageal squamous cell carcinoma: long-term results from a Western cohort Ilse N. Beaufort, Charlotte N. Frederiks, Anouk Overwater, Lodewijk A.A. Brosens, Arjun D. Koch, Roos E. Pouw, Jacques J.G.H.M. Bergman, Bas L.A.M. Weusten Endoscopy.2024; 56(05): 325. CrossRef